Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Extremities Neoplasms × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 7977 Neoplasms 5541 Prostatic Neoplasms 3751 Colorectal Neoplasms 3326 Lung Neoplasms 3029 Carcinoma, Non-Small-Cell Lung 2981 Pancreatic Neoplasms 2104 Carcinoma, Hepatocellular 2022 Leukemia, Myeloid, Acute 1890 Multiple Myeloma 1802 Stomach Neoplasms 1784 Neoplasm Metastasis 1605 Head and Neck Neoplasms 1561 Ovarian Neoplasms 1503 Brain Neoplasms 1462 Lymphoma 1448 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1443 Rectal Neoplasms 1409 Melanoma 1387 Colonic Neoplasms 1349 Leukemia 1267 Recurrence 1239 Uterine Cervical Neoplasms 1236 Glioblastoma 1115 Esophageal Neoplasms 1112 Lymphoma, Non-Hodgkin 1007 Leukemia, Lymphocytic, Chronic, B-Cell 930 Urinary Bladder Neoplasms 915 Squamous Cell Carcinoma of Head and Neck 915 Lymphoma, Follicular 878

Interventions

Electroporation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02430688 2021-09-05

IRE

Fuda Cancer Hospital, Guangzhou

Phase NA Completed

Extremities Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡